1. Constitutive Interferon Attenuates RIPK1/3-Mediated Cytokine Translation.
- Author
-
Muendlein HI, Sarhan J, Liu BC, Connolly WM, Schworer SA, Smirnova I, Tang AY, Ilyukha V, Pietruska J, Tahmasebi S, Sonenberg N, Degterev A, and Poltorak A
- Subjects
- Adaptor Proteins, Signal Transducing metabolism, Animals, Cell Cycle Proteins metabolism, Cytokines genetics, Down-Regulation, Eukaryotic Initiation Factor-4E metabolism, Female, Humans, Inflammation pathology, Lipopolysaccharides pharmacology, Macrophage Activation drug effects, Mechanistic Target of Rapamycin Complex 1 metabolism, Mice, Inbred C57BL, RNA, Messenger genetics, RNA, Messenger metabolism, Signal Transduction, Cytokines metabolism, Interferons metabolism, Protein Biosynthesis, Receptor-Interacting Protein Serine-Threonine Kinases metabolism
- Abstract
Receptor-interacting protein kinase 1 (RIPK1) and 3 (RIPK3) are well known for their capacity to drive necroptosis via mixed-lineage kinase-like domain (MLKL). Recently, RIPK1/3 kinase activity has been shown to drive inflammation via activation of MAPK signaling. However, the regulatory mechanisms underlying this kinase-dependent cytokine production remain poorly understood. In the present study, we establish that the kinase activity of RIPK1/3 regulates cytokine translation in mouse and human macrophages. Furthermore, we show that this inflammatory response is downregulated by type I interferon (IFN) signaling, independent of type I IFN-promoted cell death. Specifically, low-level constitutive IFN signaling attenuates RIPK-driven activation of cap-dependent translation initiation pathway components AKT, mTORC1, 4E-BP and eIF4E, while promoting RIPK-dependent cell death. Altogether, these data characterize constitutive IFN signaling as a regulator of RIPK-dependent inflammation and establish cap-dependent translation as a crucial checkpoint in the regulation of cytokine production., Competing Interests: Declaration of Interests The authors declare no competing interests., (Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF